StockData
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX) stock

RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/309% below fair value
$2.72−0.18 (-6.37%)

Close on Nov 17, 2026Market cap $1.46BP/E –Yield –

Recursion Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Recursion Pharmaceuticals's market cap was $1.92B on Nov 11, 2026, against $2.28B a year earlier. Over the last 5 years it ranged from $911.18M to $3.15B, with a median of $1.90B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.92B-4.7%
2025Dec 31, 2025$2.01B+4.0%
2024Dec 31, 2024$1.93B-9.3%
2023Dec 29, 2023$2.13B+58.9%
2022Dec 30, 2022$1.34B-53.5%
2021Dec 31, 2021$2.89B–

More Recursion Pharmaceuticals figures

See a number that looks wrong?